Corient Private Wealth’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.35M | Buy |
34,653
+4,862
| +16% | +$611K | ﹤0.01% | 801 |
|
|
2025
Q1 | $4.08M | Buy |
29,791
+407
| +1% | +$55.7K | 0.01% | 738 |
|
|
2024
Q4 | $4.49M | Sell |
29,384
-338
| -1% | -$51.7K | 0.01% | 737 |
|
|
2024
Q3 | $5.76M | Sell |
29,722
-3,100
| -9% | -$601K | 0.01% | 692 |
|
|
2024
Q2 | $7.61M | Buy |
32,822
+2,474
| +8% | +$574K | 0.01% | 593 |
|
|
2024
Q1 | $6.54M | Sell |
30,348
-864
| -3% | -$186K | 0.01% | 634 |
|
|
2023
Q4 | $8.08M | Buy |
31,212
+8,453
| +37% | +$2.19M | 0.01% | 572 |
|
|
2023
Q3 | $5.85M | Buy |
22,759
+642
| +3% | +$165K | 0.01% | 604 |
|
|
2023
Q2 | $6.3M | Buy |
22,117
+265
| +1% | +$75.5K | 0.01% | 569 |
|
|
2023
Q1 | $6.08M | Buy |
21,852
+7,602
| +53% | +$2.11M | 0.02% | 539 |
|
|
2022
Q4 | $3.94M | Buy |
+14,250
| New | +$3.94M | 0.01% | 549 |
|